| This week's sponsor is Premier Research. | | | Studying an Addiction Drug? Some Practical Tips To Help
Developing drugs to treat addiction is a complex challenge, and sponsors benefit when they know how addiction trials work. Read our white paper for a closer look. Premier Research. It's what we do. Best. |
Today's Rundown Cue Biopharma in $374M-plus Merck immunotherapy pact X4, nearing late-phase trials of ex-Sanofi drug, raises $27M Evelo taps Mayo Clinic expertise for therapeutic bacteria programs [Sponsored] Looking Toward Abuse Deterrent Opioids In conversation with: Alice Zhang, CEO of Verge Genomics Alnylam starts rolling FDA filing for patisiran Amid tax reform plans, ACRO urges government to allow CRO tax credits Harnessing immunotherapy to reverse Type 1 diabetes Featured Story | | | Thursday, November 16, 2017 After raising $26 million at the start of the year, cancer and autoimmune startup Cue Biopharma has ended the year with a potentially lucrative new deal with Merck. |
|
|
| This week's sponsor is Deloitte. | | | |
Top Stories Thursday, November 16, 2017 X4 Pharmaceuticals has raised $27 million to advance a CXCR4 inhibitor it picked up from Sanofi. The series B equips X4 to move deeper into the clinic on two fronts, with phase 2 and 3 trials in cancers and rare diseases on the horizon. Thursday, November 16, 2017 Evelo Biosciences has just forged closer ties with a heavyweight academic partner for its monoclonal microbials R&D, which envisions using bacteria to fight disease. Monday, November 13, 2017 The complex and intertwined dual epidemics of poorly treated pain and opioid addiction require a combined, artful approach to secure the best possible results for patients. Thursday, November 16, 2017 Alice Zhang co-founded Verge Genomics to create a scalable drug discovery engine that automates the discovery of cures across therapeutic areas. Currently focused on neurodegenerative diseases, instead of targeting only one gene at a time, Verge uses machine learning to map out the hundreds of genes that cause a disease. Thursday, November 16, 2017 Alnylam has kicked off a rolling FDA filing for its RNAi drug patisiran. The gene silencing pioneer expects to complete the submission by the end of the year, setting it up to win approval in the U.S. in 2018. Thursday, November 16, 2017 Tax reform has become a major political issue and one that President Donald Trump would dearly like to see pass. However, the CRO lobby group ACRO wants the government not only to look to the top line but also to drill down into what it can mean for research. Wednesday, November 15, 2017 In patients with Type 1 diabetes, T cells in the immune system attack islet cells in the pancreas that make insulin. Scientists at Boston Children’s Hospital have come up with a way to thwart this wayward autoimmune reaction using a protein that plays a prominent role in cancer immunotherapies: PD-L1. | This week's sponsor is Charles River. | | | |
Resources Sponsored by: Reprints Desk SO CLOSE AND YET SO FAR. Is that how many documents seem to you? Getting what you want—when, where, and how you want it—can be a real pain. That’s why we created this concise guide to getting around the obstacles that stand between you and the information your organization needs. Download the whitepaper to learn more. Presented By: Covance Global clinical trials are the trend and gaining in popularity, but running a global trial is not a straightforward process. This white paper explores some of the challenges associated with global clinical trials and considerations for ensuring that the collected data comply with the trial's overall objectives. Sponsored by: Veeva Systems See the results from one of the largest, most in-depth surveys of clinical data management professionals on data management practices, performance, and challenges. Sponsored by: Veeva Systems Gain a complete, real-time view of quality and streamline operations. Incorporate partners into processes for critical oversight and 30% greater efficiency, and transform cross-functional processes like change control. Presented by: DSM Biomedical Discover DSM's Dyneema Purity® membrane, an effective and efficient material to construct stent grafts used in minimally invasive surgeries to treat both cardiovascular and peripheral arterial diseases. Sponsored by: ePharmaSolutions As clinical trials become more complex, safety document distribution to investigative sites has reached the point that demands a solution. Sponsored by: Ashfield Healthcare December 5, 2017 | 2pm EST / 11am PST Join this webinar to learn methods that maintain and build sales momentum despite turnover. Sponsored by: Veeva CROs are leading an industry wide shift to modernize clinical systems and clinical trial processes. Presented By: Charles River Join us as we discuss how Charles River Celsis® helped Labor L+S AG validate a 7-day membrane filtration sterility test using existing protocols. Presented By: Catalent Learn how Catalent Biologics is paving the way for flexible biologics development and manufacturing through advanced technologies and fully integrated multi-product facility. Presented By: Catalent Download the eBook to get articles from various Elsevier journals highlighting developments in ADC technology. Presented By: Catalent Learn how cell development and process scale-up can be optimized for antibodies requiring additional processing. Sponsored By: RTI Health Solutions In this webinar, we will introduce the rapidly-evolving within-subject clinical trial (WSCT) methods for early phase evidence generation that require fewer people, less time, and usually less funding than traditional early phase methods. BioBasics: Biotech for the Non-Scientist November 30-December 1, 2017 | Boston, MA CBI’s Commercial Data Insights 2017 November 28-29, 2017 | Philadelphia, PA FierceBiotech Executive Breakfast: Get Good Science and the Money will Follow January 9, 2018 | San Francisco, CA Register Today – ISPE Biopharmaceutical Manufacturing Conference December 4th-6th, 2017 | San Francisco, CA BIO Asia International Conference March 19-20, 2018 | Tokyo, Japan Molecular Med Tri-Conference February 11-16, 2018 | San Francisco, CA | 